Italia markets closed

BMY Oct 2024 43.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
3,9000+0,5000 (+14,71%)
In data: 10:09AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente3,4000
Aperto3,9000
Denaro2,8100
Lettera4,1500
Prezzo d'esercizio43,00
Scadenza2024-10-18
Min-Max giorno3,9000 - 3,9000
Contratto - Min-MaxN/D
Volume60
Open Interest291
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri